Active00745839Private limited companyLoughton

DIOMED DEVELOPMENTS LIMITED

B77/100

Owned by Diomed Group Holdings Limited (75–100%)

Companies HouseCompanies House
01

Summary

Generated from filed data · no estimates

DIOMED DEVELOPMENTS LIMITED is an active private limited company (company number 00745839) incorporated on 2 January 1963, registered in Loughton. Its registered activity is manufacture of basic pharmaceutical products (SIC 21100). Latest full accounts cover the period ending 31 May 2025, showing net assets of £15.70m and cash of £16.20m, with 6 employees on average. Turnover was £21.20m and profit for the year £2.82m. Net assets fell 39% on the prior period (£25.79m).

Peer position · net assets

By net assets it sits in the top quarter of 86 comparable companies in Greater London (median £100, upper quartile £35k).

02

Key dates

Incorporated
2 January 196363 yrs ago
Next accounts due
28 February 2027in 129 days
Confirmation statement due
16 January 2027in 86 days

Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.

03

Activity

SIC 21100
Manufacture of basic pharmaceutical products
Accounts type
Full
Size band
MediumCompanies Act thresholds
04

Financials

3 periods on record · latest ending 31 May 2025
Net assets
£15.70m
−39%vs May 2024
Cash at bank
£16.20m
+6%vs May 2024
Turnover
£21.20m
+6%vs May 2024
Employees
6
No changevs May 2024
Net assets
£15.70m
Cash at bank
£16.20m
Turnover
£21.20m
Profit for the year
£2.82m
Average employees
6
Filed accounts by period, newest first
Period endNet assetsCashDebtorsCreditors <1yTurnoverProfitEmployees
31 May 2025£15.70m£16.20m—£9.54m£21.20m£2.82m6
31 May 2024£25.79m£15.25m—£8.12m£20.06m£1.04m6
1 June 2023———————
Current ratio2.62Comfortable
Net margin13.3%Profit for the year ÷ turnover
Cash per employee£2.70mCash ÷ average employees

Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.

05

Firmoscan score

Rules-based · every point shows its evidence
77 / 100 · grade B
EDCBA
Score breakdown
50Starting scoreEvery scored company starts here
+10Positive net assetsNet assets £15,698,305 at 2025-05-31
−8Net assets falling-39.1% vs prior period
+8Comfortable liquidityCurrent ratio 2.62
+4Cash reservesCash £16,202,622
+5Multi-year filing history3 periods on record
+8EstablishedIncorporated 1963-01-02 (64 years)
77Score, grade B

A transparent, rules-based score from filed data only: every point lists its evidence. It is not a credit rating or advice. How the score is computed.

06

Ownership and control

1 active · 3 other
  • Diomed Group Holdings Limited
    corporate entity, England · since 16 July 2024
    • owns 75–100% of shares
    • holds 75–100% of voting rights
    • can appoint or remove directors
  • Mr Michael Jonathan Yarrow
    Individual · since 6 April 2016 · ceased 16 July 2024
    • owns 75–100% of shares
    • holds 75–100% of voting rights
  • Diomed Group Holdings Limited
    corporate entity, England · since 16 July 2024 · ceased 16 July 2024
    • owns 75–100% of shares
    • holds 75–100% of voting rights
    • can appoint or remove directors
  • June24 Holdings Limited
    corporate entity, England · since 16 July 2024 · ceased 16 July 2024
    • owns 75–100% of shares
    • holds 75–100% of voting rights
    • can appoint or remove directors

Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents.

07

Timeline

Newest first
  1. Next accounts duein 129 days
  2. Confirmation statement duein 86 days
  3. Accounts period endNet assets £15.70m · full accounts
  4. Accounts period endNet assets £25.79m · full accounts
  5. Accounts period end
  6. Incorporated
08

Similar companies in Greater London

Same activity (manufacture of basic pharmaceutical products), closest in incorporation date
09

Reminders for DIOMED DEVELOPMENTS LIMITED

Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.